SBI ALApromo Co., Ltd   Report issue

For profit
Founded: Tokyo Japan (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2011
NCT01380548
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

SBI ALApromo Co., Ltd., Japan | SBI ALApromo Co., Ltd. - Strategic Business Innovator

Active Ingredients

Drugs in Other Trials (2)

aminolevulinic acid (levulan) (2 trials)

iron (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2